After more than a decade of global consultation, polycystic ovary syndrome (PCOS) – a condition that affects one in eight women – has been renamed.
The hormonal disorder, estimated to affect 170 million women worldwide, will now be known as polyendocrine metabolic ovarian syndrome (PMOS).